Medicus Pharma(NASDAQ) MDCXW

Market CapN/A

Since IPO (2024)-42%

5 YearN/A

1 Year-66%

1 Month+0%

$0.35

-0.03%

-0.00Today

Medicus Pharma last closing stock price
Metric	Price	Date
Last close	USD 0.35	2026-07-27

Medicus Pharma stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-10.26%	USD 0.39	2026-07-20
1 month	+0%	USD 0.35	2026-06-26
3 month	-51.38%	USD 0.72	2026-04-28
Year to date	-56.25%	USD 0.80	2025-12-31
1 year	-66.02%	USD 1.03	2025-07-25
Since inception	-41.62%	USD 0.60	2024-11-14

Medicus Pharma Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$0.00

Net Income (TTM)

-$36.93M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$0.35

Volume

833

Open

$0.35

Price

$0.35

Volume

833

Open

$0.35

Previous Close

$0.35

Daily Range

$0.35 - $0.35

52-Week Range

$0.20 - $1.45

Estimated Earnings Date

Aug 20, 2026

Dividend

$0.00

Beta (Volatility)

0.84 (Low)

Price

$0.35

Volume

833

Open

$0.35

Previous Close

$0.35

Daily Range

$0.35 - $0.35

52-Week Range

$0.20 - $1.45

Estimated Earnings Date

Aug 20, 2026

MDCXW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medicus Pharma

Medicus Pharma Ltd. is a biotechnology company focused on advancing clinical development programs for innovative therapeutic assets. The company is headquartered in Toronto, Canada, and is dedicated to developing SkinJectTM, a product aimed at treating basal cell carcinoma.

Products and Services

SkinJectTM for basal cell carcinoma treatment
Research and development of novel therapeutic assets
Clinical trial management and support services

Growth Outlook

Significant investment in R&D, with $2.7 million in Q1 2026
Strong pipeline with potential for future product launches
Focus on expanding market presence in the biotechnology sector

Financial Highlights

Net income of -$6.6 million in Q1 2026
Cash and cash equivalents of $6.4 million as of March 31, 2026
Operating expenses of $6.3 million in Q1 2026

Medicus Pharma Ltd. operates in a dynamic and competitive biotechnology landscape, with a clear focus on developing innovative solutions for unmet medical needs. The company's commitment to research and development is evident in its substantial investment in clinical programs, which positions it well for future growth. Despite recent financial challenges, the available cash reserves provide a foundation for ongoing operations and potential expansion. Investors may find the company's strategic direction and product development efforts noteworthy as it seeks to establish a stronger foothold in the healthcare sector.

AI Generated • Jul 4, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Conshohocken, PA 19428, CA

MDCXW Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-4086.31%

Return on Capital

-467.18%

Return on Assets

-497.30%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

Volume

833

Avg. Volume

3.75K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$35.50M

EBITDA

-$37.11M

Operating Cash Flow

-$23.41M

Capital Expenditure

$3.00

Free Cash Flow

-$23.41M

Cash & ST Invst.

$6.37M

Total Debt

$169.62K

Medicus Pharma Performance Analysis

Medicus Pharma sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	N/A
Q3	2025-09-30	N/A
Q4	2025-12-31	N/A
Q1	2026-03-31	N/A

Medicus Pharma sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	-2.4%
Q3	2025-09-30	-160.5%
Q4	2025-12-31	61.6%
Q1	2026-03-31	48.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$6.59M

-29.2%

EBITDA

-$6.97M

-36.5%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$6.37M

+59.8%

Total Debt

$169.62K

-42.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$24.17K

-86.1%

Short Term Debt

$145.46K

+20.9%

Return on Assets

-4.97%

N/A

Return on Invested Capital

-24.10%

N/A

Free Cash Flow

-$6.51M

-65.2%

Operating Cash Flow

-$6.51M

-65.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OTLKOutlook Therapeutics, Inc.

OTLKOutlook Therapeutics, Inc.$1.07-24.20%

NRXPNRx Pharmaceuticals, Inc.

NRXPNRx Pharmaceuticals, Inc.$3.63-3.20%

SPRBSpruce Biosciences, Inc.

SPRBSpruce Biosciences, Inc.$41.99-2.53%

ICCCImmuCell Corporation

ICCCImmuCell Corporation$11.13+0.91%

CUECue Biopharma, Inc.

CUECue Biopharma, Inc.$32.57+1.40%

IOBTIO Biotech, Inc.

IOBTIO Biotech, Inc.$0.01-27.59%

FBIOFortress Biotech, Inc.

FBIOFortress Biotech, Inc.$3.27-2.10%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$91.67-0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.25+0.10%

NOKNokia

NOKNokia$9.28+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.95+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.24-0.02%

TAT&T

TAT&T$24.42+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$63.40-0.01%

Questions About MDCXW

What is the current price of Medicus Pharma?

Medicus Pharma is trading at $0.35 per share.

What is the 52-week range for Medicus Pharma?

Over the past 52 weeks, Medicus Pharma has traded between $0.20 and $1.45.

How much debt does Medicus Pharma have?

Medicus Pharma total debt is unavailable.

How much cash does Medicus Pharma have on hand?

Medicus Pharma does not have cash on hand data available.

What is Medicus Pharma’s dividend yield?

Medicus Pharma does not currently have a dividend yield.

Medicus Pharma(NASDAQ) MDCXW

Medicus Pharma Financials at a Glance

MDCXW News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Medicus Pharma

MDCXW Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Medicus Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About MDCXW

What is the current price of Medicus Pharma?

What is the 52-week range for Medicus Pharma?

How much debt does Medicus Pharma have?

How much cash does Medicus Pharma have on hand?

What is Medicus Pharma’s dividend yield?

Premium Investing Services